Investor Relations Captor Therapeutics ®
Communication from the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) on the conditional registration of ordinary bearer shares of series P
Current report no. 51/2023
Drafting date: 27 October 2023.
Subject: Communication from the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) on the conditional registration of ordinary bearer shares of series P
Legal basis: Article 56(1)(2) of the Act on Offering - current and periodic information
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the "Company"), has become aware of the National Depository for Securities' ("NDS") Announcement No. 1008/2023 on the conclusion, at the request of the Company, of an agreement for the registration in the securities depository of 400,000 series P ordinary bearer shares and, with a nominal value of PLN 0.10 each and ISIN code PLCPTRT00014.
The registration of the shares is conditional and will take place within 3 days of the receipt by the NDS of a decision to introduce the above shares to trading on the regulated market to which other shares of the Company bearing the above ISIN code have been introduced, but not earlier than the date indicated in that decision as the date of introduction of those shares to trading on that regulated market.
Detailed legal basis:
§17(1)(1) of the RMF on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required by the laws of a non-member state